Novobrace Information

Novobrace, an injectable bioadhesive, treats tendon and ligament injuries in all breeds of working and competitive horses, as well as, other animals. Novobrace provides immediate benefits by forming an internal cast within the tendon to immediately stabilize and prevent the injury from spreading which allows faster recovery time. Novobrace has been evaluated and tested by leading veterinarians across the USA and the outcomes far surpass the expectations of treating clinicians. Novobrace technology reduces rehabilitation and recovery time by as much as 50% as compared to other treatment options. Novobrace may be used as a standalone treatment or as a complementary therapy. Clinical indications include the treatment of superficial digital tendons, deep digital flexor tendons and suspensory ligaments with or without lesion. Novobrace is a product of Equinext, which is a spinoff company of Orthopeutics with offices and laboratory on the University of Kentucky’s Coldstream Research Campus in Lexington, Ky.